The article discusses ARK stocks and Cathie Wood's investment approach, focusing on disruptive innovation. It highlights CRISPR Therapeutics AG (NASDAQ:CRSP) and its potential in the gene sequencing industry. The stock ranks 3rd on the list of worst ARK stocks by short sellers.